BMS ’s Opdivo stumbles in late-stage cancer trial

The immuno-oncology treatment recently hit a roadblock in a trial targeting patients with glioblastoma multiforme.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news